StrideBio: StrideBio Announces Achievement of Significant Operational Milestones Supporting Transition of Novel Gene Therapy Pipeline to Clinical Stage

(marketscreener.com) - 100th team member hired, bolstering internal capabilities from capsid platform to clinic with an emphasis on in-house manufacturing capability - - Completed construction of GMP manufacturing facility with 1000L production capacity to support clinical trials - - Current HQ expanded to 47,000 sq ft incorporating additional state-of-art...https://www.marketscreener.com/news/latest/StrideBio-Announces-Achievement-of-Significant-Operational-Milestones-Supporting-Transition-of-Novel--36593099/?utm_medium=RSS&utm_content=20211004